Back to top

LACOG 0318 – Induction

  /    /  LACOG 0318 – Induction

Randomized, Open-label, Phase III Trial of Induction Chemotherapy Followed by Chemoradiotherapy versus Upfront Chemoradiotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

Type of Study: Clinical Trial

Sponsor / Support: LACOG, Hospital de Câncer de Barretos

Primary Objectives: Compare 3-year Overall Survival rates

Design: Phase III, open, randomized clinical trial comparing chemoradiotherapy (arm A) versus induction chemotherapy followed by chemoradiotherapy (arm B)

Sample Size: 376 to 414 patients

Principal Investigator: Pedro Rafael Martins De Marchi

Countries LATAM: Brazil